Connaughton Bernadette is a director of Syneos Health, Inc.
Person profile
Roles
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Editas Medicine, Inc.
3 Jun 24
4
HALOZYME THERAPEUTICS, INC.
29 Apr 24
4
Syneos Health, Inc.
28 Sep 23
4
Editas Medicine, Inc.
5 Jun 23
4
Syneos Health, Inc.
30 May 23
4
HALOZYME THERAPEUTICS, INC.
9 May 23
4
HALOZYME THERAPEUTICS, INC.
17 Nov 22
4
Editas Medicine, Inc.
13 Jun 22
4
Syneos Health, Inc.
27 May 22
4
HALOZYME THERAPEUTICS, INC.
6 May 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 May 24 | EDIT Editas Medicine | Stock Option (right to buy) Common Stock | Grant | Acquire A | No | No | 5.17 | 25,000 | 129.25 k | 25,000 |
25 Apr 24 | HALO Halozyme Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 6,501 | 0.00 | 46,787 |
25 Apr 24 | HALO Halozyme Therapeutics | Option to Purchase Common Stock Common Stock | Grant | Acquire A | No | No | 38.46 | 8,804 | 338.60 k | 8,804 |
28 Sep 23 | SYNH Syneos Health | Class A Common Stock | Sale back to company | Dispose D | No | No | 0 | 4,863 | 0.00 | 0 |
28 Sep 23 | SYNH Syneos Health | Class A Common Stock | Sale back to company | Dispose D | No | No | 43 | 9,915 | 426.35 k | 4,863 |
1 Jun 23 | EDIT Editas Medicine | Stock Option Common Stock | Grant | Acquire A | No | No | 9.55 | 25,000 | 238.75 k | 25,000 |
25 May 23 | SYNH Syneos Health | Class A Common Stock | Grant | Acquire A | No | No | 0 | 4,863 | 0.00 | 14,778 |